Cancer of Cervix

26 registered clinical trials studyying Cancer of Cervix — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. NCT06786429	Eunice Dube	Phase 4
Unknown	Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer NCT06147960	Centre Hospitalier Universitaire de Nīmes	—
Not Yet Recruiting	Minimally Invasive Therapy Versus Open Radical Hysterectomy for Management of Early Stage Cervical Cancer NCT04999696	Chang Gung Memorial Hospital	N/A
Completed	The Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and Belief NCT05990270	Kahramanmaras Sutcu Imam University	N/A
Not Yet Recruiting	Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immun NCT05824494	Women's Hospital School Of Medicine Zhejiang University	Phase 2
Completed	Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium a NCT05742711	DyAnsys, Inc.	N/A
Active Not Recruiting	Tempus Priority Study: A Pan-tumor Observational Study NCT05179824	Tempus AI	—
Unknown	The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Y NCT04022148	University of Fukui	—
Unknown	The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor NCT03896958	SpeciCare	—
Completed	High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs NCT03653819	Herlev and Gentofte Hospital	N/A
Completed	Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study NCT05149248	Instituto Nacional de Salud Publica, Mexico	Phase 2 / Phase 3
Recruiting	SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774	Massive Bio, Inc.	—
Completed	Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy NCT04809727	Tanta University	N/A
Completed	Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) NCT03133286	DxTerity Diagnostics	—
Completed	Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal NCT02865135	Dana-Farber Cancer Institute	Phase 1 / Phase 2
Active Not Recruiting	Follow-up of Cell Changes in the Cervix NCT05709730	Karolinska University Hospital	—
Withdrawn	Ph Ib/BGJ398/Cervix and Other Solid Tumors NCT02312804	The University of Texas Health Science Center at San Antonio	Phase 1
Completed	Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients NCT02309658	Professor Fernando Figueira Integral Medicine Institute	Phase 2
Unknown	The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies NCT00726635	Rabin Medical Center	Phase 3
Completed	Para-Aortic Lymph Nodal Staging & Evaluation of Treatment Outcome by 18F FDG-PET in Advanced Cancer Cervix NCT00193752	Tata Memorial Hospital	—
Completed	A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage II NCT00193804	Tata Memorial Hospital	—
Unknown	The Correlation Between the Haplotype of Human Leukocyte Antigen (HLA) and Human Papillomavirus NCT00154479	National Taiwan University Hospital	—
Unknown	Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix NCT00193739	Tata Memorial Hospital	Phase 3
Completed	Concomitant Chemoradiation in Advanced Stage Carcinoma Cervix NCT00193791	Tata Memorial Hospital	N/A
Completed	Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervi NCT00191100	Eli Lilly and Company	Phase 3
Completed	High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix NCT00193830	Tata Memorial Hospital	Phase 3